The Dynamic Range of Site-1 Protease Functions in Skeletal Development
骨骼发育中 Site-1 蛋白酶功能的动态范围
基本信息
- 批准号:9032449
- 负责人:
- 金额:$ 33.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-01 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAdolescentAntibodiesBinding ProteinsBiologicalBiological ProcessBone DensityBone DevelopmentBone GrowthC-terminalCalciumCartilageCartilage MatrixCellsChondrocytesCollagen Type IIComplexConnective TissueConsensus SequenceCoupledDefectDeformityDegenerative polyarthritisDevelopmentDown-RegulationDwarfismEmbryoEndoplasmic ReticulumEnzymesExhibitsFluorescence Resonance Energy TransferFluorescent DyesFoundationsFura-2FutureGenesGrowth and Development functionHealthHomeostasisImageIntervertebral disc structureInvestigationKnock-outKnockout MiceKnowledgeKyphosis deformity of spineLaboratoriesLeadLightLipidsMaintenanceMass Spectrum AnalysisMembraneMembrane LipidsMicroarray AnalysisModelingMolecularMusOsteoblastsOsteocalcinOsteogenesisPathologyPathway interactionsPeptide HydrolasesPhenotypePhosphorylationPlayProcessProcollagenPropertyProprotein ConvertasesProteinsProteolysisRegulationRegulatory ElementRoleShapesSignal PathwaySkeletal DevelopmentSkeletonSpectrometry, Mass, Electrospray IonizationStagingSterolsSystemTransforming Growth Factor betaType II ProcollagenVertebral columnVertebratesbiological adaptation to stressbonecartilage developmentchondrodysplasiaclinical phenotypedesignendoplasmic reticulum stressfallsgel electrophoresisinsightlipid metabolismlong bonemouse modelnovelnovel strategiesnovel therapeuticsparathyroid hormone (1-34)postnatalprogramsresponsescoliosissecretion processsecretory proteinsite-1 proteaseskeletalskeletal abnormalityspine bone structuretraffickingtranscription factortwo-dimensional
项目摘要
DESCRIPTION (provided by applicant): The proprotein convertase Site-1 protease (S1P) has emerged as a critical regulator of mammalian skeletal development. It is an indispensable component of the regulated intramembrane proteolysis systems that govern lipid metabolism and endoplasmic reticulum stress response. Our studies implicate S1P as a mandatory component of the protein secretory apparatus that defines all connective tissues. We have studied the functions of S1P in a progressive set of S1P knock-out mouse models using Col2-Cre, Col2-CreER(T) and Osx-Cre mice. In addition to a lipid phenotype, studies on S1P ablation in chondroprogenitor cells (S1Pcko model) have demonstrated chondrodysplasia characterized by the specific endoplasmic reticulum (ER) entrapment of type IIB procollagen, poor cartilage matrix development, and loss of endochondral bone formation in mice. Our recent studies demonstrated that along with type IIB procollagen, chondrocytes are also unable to secrete Adamts3, the type II procollagen N-proteinase. We have discovered a well-conserved S1P consensus sequence in the C-terminus of Adamts3, which suggests mandatory C-terminal processing of Adamts3 by S1P. Post-natal S1P ablation in chondrocytes (using Col2-CreER(T)) demonstrated complete disruption of hypertrophic chondrocyte differentiation. When we followed this observation by ablating S1P in prehypertrophic chondrocytes and osteoblasts using Osx-Cre mice, adolescent mice exhibited kyphosis and scoliosis coupled to chondrodysplasia and fragile long bones. These observations confirm the requirement of S1P to overall skeletal development and suggest potential cell-specific functions for S1P. Our mechanistic characterization of the S1Pcko model has demonstrated that lipid metabolism is down-regulated in S1Pcko chondrocytes. Disrupted ER membrane functions induced by changes in lipid composition may trap the type IIB procollagen in the ER. In light of these findings, in Specific Aim 1 we will investigate deviations in S1Pcko ER membrane lipid composition by mass spectrometry and analyze disrupted ER membrane functions by calcium imaging. In Specific Aim 2 we will investigate Adamts3 as a novel S1P substrate and analyze whether type IIB procollagen trafficking is regulated by a physical association with Adamts3. We will also study cartilage-specific ablation of Adamts3 in mice to analyze its role in cartilage development and maintenance. In Specific Aim 3, taking the lead from our previous knock-out models, we will characterize how disruptions in chondrocyte and osteoblast functions due to S1P ablation could lead to spine abnormalities in order to identify the biological trigger required
for kyphosis and scoliosis development. This approach will allow investigation of multiple novel functions of S1P; additionally it will also provide novel insights into the regulation of protein secretory pathways and how their disruptions lead to the clinical phenotypes of chondrodysplasia and spine deformities.
描述(由应用程序提供):促蛋白转化酶Site-1蛋白酶(S1P)已成为哺乳动物骨骼发育的关键调节剂。它是控制脂质代谢和内质网应激反应的受调节膜内蛋白水解系统的必不可少的组成部分。我们的研究暗示S1P是定义所有连接组织的蛋白质秘密设备的强制性组成部分。我们使用COL2-CRE,COL2-CREER(T)和OSX-CRE小鼠研究了S1P的功能。除了脂质表型外,对软骨元素细胞中S1P消融的研究(S1PCKO模型)表明,软骨增生到具有特定内质网(ER)特异性的软骨膜膜片(ER)的特征。我们最近的研究表明,与IIB型Procollagen一起,软骨细胞也无法秘密秘密ADAMTS3,即II型胶原蛋白酶N-蛋白酶。我们已经在ADAMTS3的C端发现了保存良好的S1P共识序列,这表明S1P对ADAMTS3进行了强制性的C末端处理。在软骨细胞中(使用COL2-CREER(T))中产后S1P消融表现出肥大软骨细胞分化的完全破坏。当我们通过使用OSX-CRE小鼠的植物性软骨细胞和成骨细胞进行消融S1P进行观察时,青少年小鼠暴露于脊柱侧弯和脊柱侧弯与软骨浮肿和脆弱的长骨相连。这些观察结果证实了S1P对总体骨骼发育的要求,并提出了S1P的潜在细胞特异性功能。我们对S1PCKO模型的机械表征表明,脂质代谢在S1PCKO软骨细胞中被下调。脂质组合物变化引起的破坏ER膜功能可能会捕获ER中的IIB型Procollagen。鉴于这些发现,在特定的目标1中,我们将通过质谱法研究S1PCKO ER膜脂质组成中的出发,并通过钙成像分析了破坏的ER膜功能。在特定的目标2中,我们将研究ADAMTS3作为新型S1P底物,并分析IIB型Procollagen贩运是否受到与ADAMTS3的物理关联调节。我们还将研究小鼠ADAMTS3的软骨特异性消融,以分析其在软骨发育和维持中的作用。在特定的目标3中,从我们以前的淘汰模型中脱颖而出,我们将表征由于S1P消融而引起的软骨细胞和成骨细胞功能的破坏可能导致脊柱异常,以识别所需的生物学触发因素
用于脑脊柱和脊柱侧弯的发展。这种方法将允许研究S1P的多个新功能。此外,它还将提供有关蛋白质分泌途径调节的新见解,以及它们的破坏如何导致软骨发育不良和脊柱畸形的临床表型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Debabrata Patra其他文献
Debabrata Patra的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
自然接触对青少年网络问题行为的作用机制及其干预
- 批准号:72374025
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
大气污染物对青少年心理健康的影响机制研究
- 批准号:42377437
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
心肺耐力对青少年执行功能影响效应及其特定脑区激活状态的多民族研究
- 批准号:82373595
- 批准年份:2023
- 资助金额:47 万元
- 项目类别:面上项目
中国父母情绪教养行为对青少年非自杀性自伤的影响及其机制
- 批准号:32300894
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
执行技能训练联合动机行为治疗对注意缺陷多动障碍青少年疗效及脑机制
- 批准号:82371557
- 批准年份:2023
- 资助金额:65 万元
- 项目类别:面上项目
相似海外基金
PROgression of Tuberculosis infECTion in young children living with and without HIV: the PROTECT study
感染和未感染艾滋病毒的幼儿结核感染的进展:PROTECT 研究
- 批准号:
10641389 - 财政年份:2023
- 资助金额:
$ 33.55万 - 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 33.55万 - 项目类别:
Incidence and Time on Onset of Cardiovascular Risk Factors and Cardiovascular Disease in Adult Survivors of Adolescent and Young Adult Cancer and Association with Exercise
青少年和青年癌症成年幸存者心血管危险因素和心血管疾病的发病率和时间以及与运动的关系
- 批准号:
10678157 - 财政年份:2023
- 资助金额:
$ 33.55万 - 项目类别:
Targeting Macrophages to Treat Soft Tissue Sarcomas
靶向巨噬细胞治疗软组织肉瘤
- 批准号:
10760719 - 财政年份:2023
- 资助金额:
$ 33.55万 - 项目类别:
URIL tags for intracellular RNA tracking and RNP proximity labeling
用于细胞内 RNA 追踪和 RNP 邻近标记的 URIL 标签
- 批准号:
10738661 - 财政年份:2023
- 资助金额:
$ 33.55万 - 项目类别: